Verge Genomics’ Post

View organization page for Verge Genomics, graphic

15,018 followers

We're pleased to partner with Ferrer to co-develop VRG50635, our lead drug candidate for the treatment of sporadic and familial forms of #ALS. Hear our President and Chief Business Officer, Jane Rhodes, share how our #innovation and Ferrer's experience create a complementary partnership as we progress a potential treatment for this devastating disease. #biotechnology #drugdevelopment 

View organization page for Ferrer, graphic

95,461 followers

We are delighted to announce an important news for people living with amyotrophic lateral sclerosis (ALS), their families, and their caregivers, thanks to our a strategic collaboration with Verge Genomics to co-develop one of the first drugs to enter clinical trials that was entirely discovered and developed using an AI-enabled platform.   According to Mario Rovirosa, our CEO, "in line with our purpose to use business to fight for social justice, we are reinforcing our commitment to bring transformative therapeutic solutions for people living with severe and debilitating diseases”.   We are Ferrer. Ferrer for good 💙💚 More info: https://lnkd.in/diWtUBMx

Joanne Taylor

SVP Research at Gain Therapeutics

4mo

Congratulations Jane Rhodes

Like
Reply
Ruhi Khan

Chief Business Officer at Caribou Biosciences

4mo

Congratulations Jane Rhodes

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics